In this issue:
AGA Clinical Practice Update: Intestinal ultrasound for IBD
ECCO guidelines on therapeutics in Crohn’s disease
Medical treatment
Surgical treatment
PBAC recommendations
Upcoming PBAC agenda
PBS listings
Risankizumab approved for ulcerative colitis in the US and Europe
Status of IL-23 inhibitors for IBD in Australia
Stage 3 60-day prescriptions
Novel IBD guidelines imminent
IBD linked to increased risk of type 1 diabetes
Early follow-up after hospitalisation reduces readmissions
COVID-19 Resources
Conferences, workshops, and CPD
Please login below to download this issue (PDF)